Skip to main content

Advertisement

SpringerLink
Log in

Molecular imaging and therapy—a programme based on the development of new biomolecules

  • Editorial
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Wefsissleder R, Mahmood U. Molecular imaging. Radiology 2001;219:316–33

    PubMed  Google Scholar 

  2. Massoud TF, Gambhir SS. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 2003;17:545–80

    Article  PubMed  Google Scholar 

  3. Austin JL. Zen and the brain. Cambridge: MIT Press; 1999

    Google Scholar 

  4. Haberkorn U, Altmann A, Eisenhut M. Functional genomics and proteomics—the role of nuclear medicine. Eur J Nucl Med 2002;29:115–32

    Article  Google Scholar 

  5. Haberkorn U, Altmann A, Mier W, Eisenhut M. Impact of functional genomics and proteomics on radionuclide imaging. Semin Nucl Med 2004;34:4–22

    Article  Google Scholar 

  6. Ryu DDY, Nam DH. Recent progress in biomolecular engineering. Biotechnol Prog 2000;16:2–16

    Article  PubMed  Google Scholar 

  7. Wong D, Robertson G. Applying combinatorial chemistry and biology to food research. J Agric Food Chem 2004;52:7187–98

    Article  PubMed  Google Scholar 

  8. Smithgall TE. SH2 and SH3 domains: potential targets for anti-cancer drug design. J Pharmacol Toxicol Methods 1995;34:125–32

    Article  PubMed  Google Scholar 

  9. Gaisser S, Kellenberger L, Kaja A, Weston AJ, Lill RE, Wirtz G, et al. Direct production of avermectin-like drugs after domain exchange in the avermectin polyketide synthase of Streptomyces avermitilis ATCC31272. Org Biomol Chem 2003;1:2840–7

    Article  PubMed  Google Scholar 

  10. Hecht MH, Das A, Go A, Bradley LH, Wei Y. De novo proteins from designed combinatorial libraries. Protein Sci 2004;13:1711–23

    Article  PubMed  Google Scholar 

  11. Dennett DC. Darwin’s dangerous idea. New York: Simon and Schuster; 1995

    Google Scholar 

  12. Stemmer WPC. Rapid evolution of protein in vitro by DNA shuffling. Nature 1994;370:389–91

    PubMed  Google Scholar 

  13. Smith GP. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 1985;228:1315–7

    PubMed  Google Scholar 

  14. Smith GP, Petrenko VA. Phage display. Chem Rev 1997;97:391–410

    Google Scholar 

  15. Koivunen E, Arap W, Valtanen H, Rainisalo A, Medina OP, Heikkila P, et al. Tumor targeting with a selective gelatinase inhibitor. Nat Biotechnol 1999;17:768–74

    Article  PubMed  Google Scholar 

  16. Pasqualini R. Vascular targeting with phage peptide libraries. Q J Nucl Med 1999;43:159–62

    PubMed  Google Scholar 

  17. Burg MA, Pasqualini R, Arap W, Ruoslahti E, Stallcup WB. NG2 proteoglycan-binding peptides target tumor neovasculature. Cancer Res 1999;59:2869–74

    PubMed  Google Scholar 

  18. Oyama T, Sykes KF, Samli KN, Minna JD, Johnston SA, Brown KC. Isolation of lung tumor specific peptides from a random peptide library: generation of diagnostic and cell-targeting reagents. Cancer Lett 2003;202:219–30

    Article  PubMed  Google Scholar 

  19. Zitzmann S, Krämer S, Mier W, Mahmut M, Fleig J, Altmann A, et al. Identification of a new prostate specific cyclic peptide with the bacterial FLITRX system. J Nucl Med 2005;46:782–5

    PubMed  Google Scholar 

  20. Zitzmann S, Mier W, Schad A, Kinscherf R, Askoxylakis V, Krämer S, et al. A new prostate carcinoma binding peptide (DUP-1) for tumor imaging and therapy. Clin Cancer Res 2005;11:139–46

    PubMed  Google Scholar 

  21. Mattheakis LC, Bhatt RR, Dower WJ. An in vitro polysome display system for identifying ligands from very large peptide libraries. Proc Natl Acad Sci U S A 1994;91:9022–6

    PubMed  Google Scholar 

  22. Lipovseka D, Plueckthun A. In-vitro protein evolution by ribosome display and mRNA display. J Immunol Methods 2004;290:51–67

    Article  PubMed  Google Scholar 

  23. Hanes J, Schaffitzel C, Knappik A, Plückthun A. Picomolar affinity antibodies from a fully synthetic naive library selected and evolved by ribosome display. Nat Biotechnol 2000;18:1287–92

    Article  PubMed  Google Scholar 

  24. Roberts RW, Szostak JW. RNA-peptide fusions for the in vitro selection of peptides and proteins. Proc Natl Acad Sci U S A 1997;94:12297–302

    Article  PubMed  Google Scholar 

  25. Keefe AD, Szostak JW. Functional proteins from a random-sequence library. Nature 2001;410:715–8

    Article  PubMed  Google Scholar 

  26. Mathonet P, Fastrez J. Engineering of non-natural receptors. Curr Opin Struct Biol 2004;14:505–11

    Article  PubMed  Google Scholar 

  27. Xu LH, Aha P, Gu K, Kuimelis RG, Lam T, Lim AC, et al. Directed evolution of high affinity antibody mimics using mRNA display. Chem Biol 2002;9:933–42

    Article  PubMed  Google Scholar 

  28. Baggio R, Burgstaller P, Hale SP, Putney AR, Lane M, Lipovsek D, et al. Identification of epitope-like consensus motifs using mRNA display. J Mol Recognit 2002;15:126–34

    Article  PubMed  Google Scholar 

  29. Binz HK, Stumpp MT, Forrer P, Amstutz P, Plückthun A. Designing repeat proteins: well-expressed, soluble and stable proteins from combinatorial libraries of consensus ankyrin repeat proteins. J Mol Biol 2003;332:489–503

    Article  PubMed  Google Scholar 

  30. Ronald R. Breaker natural and engineered nucleic acids as tools to explore biology. Nature 2004;432:838–45

    Article  PubMed  Google Scholar 

  31. Suess B, Fink B, Berens C, Stenz R, Hillen W. A theophylline responsive riboswitch based on helix slipping controls gene expression in vivo. Nucleic Acids Res 2004;32:1610–4

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, University of Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany

    Uwe Haberkorn

  2. Department of Radiopharmaceutical Chemistry, German Cancer Research Centre, Im Neuenheimer Feld 280, 69120, Heidelberg, Germany

    Michael Eisenhut

Authors
  1. Uwe Haberkorn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael Eisenhut
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Uwe Haberkorn.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Haberkorn, U., Eisenhut, M. Molecular imaging and therapy—a programme based on the development of new biomolecules. Eur J Nucl Med Mol Imaging 32, 1354–1359 (2005). https://doi.org/10.1007/s00259-005-1924-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-005-1924-7

Search

Navigation